The Pharmacology of Cannabinoids in Chronic Pain
Abstract Background: Our objective was to provide an overview of the currently available scientific and clinical data supporting the use…
Cannabidiol (CBD)
Patterns of cannabidiol use among marijuana users in the United States
Abstract Background: As more and more states are legalizing marijuana use for medical purposes, cannabidiol (CBD) products have gained significant…
Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination
Abstract Background: Intravenous nanoemulsions (NEs) are gaining attention as potential delivery systems for poorly water-soluble substances like cannabidiol (CBD). This…
Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports
Abstract Data addressing safety concerns related to potential drug interactions between cannabis‐derived products and pharmaceutical medications in the pediatric population…
Impact of Long-Term Cannabidiol (CBD) Treatment on Mouse Kidney Transcriptome
Abstract Background: Cannabidiol, which is one of the main cannabinoids present in Cannabis sativa plants, has been shown to have…
Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials
Abstract Background: Cannabinoids have been of increasing interest mainly due to their putative efficacy in a wide array of psychiatric,…
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis
Abstract To date, no psychotropic medication has shown to effectively halt progression to psychosis among individuals at Clinical High-Risk for…
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Abstract Background: Emerging evidence supports cannabidiol (CBD) as a promising therapeutic compound for various health conditions, despite its approval as…
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
Abstract Background: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders.…
Cannabidiol (CBD) modulates the transcriptional profile of ethanol-exposed human dermal fibroblast cells
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s13353-024-00915-7. Article type: Research Article Keywords: Alcohol use disorder,…